4//SEC Filing
EYEGATE PHARMACEUTICALS INC 4
Accession 0001144204-17-012195
$KPRXCIK 0001372514operating
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 5:24 PM ET
Size
7.0 KB
Accession
0001144204-17-012195
Insider Transaction Report
Form 4
GOLDBERG MORTON
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2017-02-27−1,083→ 1,917 totalExercise: $1.70Exp: 2026-01-25→ Common Stock (1,083 underlying) - Exercise/Conversion
Common Stock
2017-02-27$1.70/sh+1,083$1,841→ 18,360 total
Footnotes (1)
- [F1]The reporting person was granted an option to purchase these shares pursuant to the Issuer's 2014 Equity Incentive Plan. The option became exercisable as to 33% of the shares underlying the option on January 25, 2017, with 2.78% of the shares underlying the option vesting monthly thereafter.
Documents
Issuer
EYEGATE PHARMACEUTICALS INC
CIK 0001372514
Entity typeoperating
Related Parties
1- filerCIK 0001372514
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 5:24 PM ET
- Size
- 7.0 KB